File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1111/anae.14511
- Scopus: eid_2-s2.0-85059456089
- PMID: 30604417
- WOS: WOS:000454713100010
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Pre-operative cardiac optimization: a directed review
Title | Pre-operative cardiac optimization: a directed review |
---|---|
Authors | |
Keywords | cardiac morbidity: pre‐operative factors heart failure hypertension valvular disease |
Issue Date | 2019 |
Publisher | Wiley-Blackwell Publishing Ltd. The Journal's web site is located at http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2044 |
Citation | Anaesthesia, 2019, v. 74 n. S1, p. 67-69 How to Cite? |
Abstract | Cardiac events remain the leading cause of peri‐operative morbidity and mortality, and patients undergoing major surgery are exposed to significant risks which may be preventable and modifiable. Proper assessment and management of various cardiac conditions in the peri‐operative period by anaesthetists can markedly improve patient safety, especially in high‐risk patient populations. This involves understanding and applying current evidence‐based practice and international guidelines on the main aspects of cardiac optimisation, including management of patients with hypertension, chronic heart failure, valvular heart diseases and cardiac implantable electronic devices. Peri‐operative management of antihypertensive drugs in keeping with the current best evidence is discussed. Pre‐operative cardiac risk assessment and cardiac biomarkers can be used to help predict and quantify peri‐operative adverse cardiac events. There is an increasing need for anaesthetist‐led services, including focused transthoracic echocardiography and management of implantable cardiac electronic devices. Anaesthetists should be encouraged to play a proactive role in pre‐operative risk stratification and make timely multidisciplinary referrals if necessary. A personalised approach to pre‐operative cardiac optimisation enables a safer peri‐operative journey for at‐risk patients undergoing major surgery. |
Description | Link to Free access; Special Issue: Patient optimisation before surgery |
Persistent Identifier | http://hdl.handle.net/10722/272821 |
ISSN | 2021 Impact Factor: 12.893 2020 SCImago Journal Rankings: 1.839 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ip, LKK | - |
dc.contributor.author | Tsai, PNW | - |
dc.contributor.author | Irwin, MG | - |
dc.date.accessioned | 2019-08-06T09:17:11Z | - |
dc.date.available | 2019-08-06T09:17:11Z | - |
dc.date.issued | 2019 | - |
dc.identifier.citation | Anaesthesia, 2019, v. 74 n. S1, p. 67-69 | - |
dc.identifier.issn | 0003-2409 | - |
dc.identifier.uri | http://hdl.handle.net/10722/272821 | - |
dc.description | Link to Free access; Special Issue: Patient optimisation before surgery | - |
dc.description.abstract | Cardiac events remain the leading cause of peri‐operative morbidity and mortality, and patients undergoing major surgery are exposed to significant risks which may be preventable and modifiable. Proper assessment and management of various cardiac conditions in the peri‐operative period by anaesthetists can markedly improve patient safety, especially in high‐risk patient populations. This involves understanding and applying current evidence‐based practice and international guidelines on the main aspects of cardiac optimisation, including management of patients with hypertension, chronic heart failure, valvular heart diseases and cardiac implantable electronic devices. Peri‐operative management of antihypertensive drugs in keeping with the current best evidence is discussed. Pre‐operative cardiac risk assessment and cardiac biomarkers can be used to help predict and quantify peri‐operative adverse cardiac events. There is an increasing need for anaesthetist‐led services, including focused transthoracic echocardiography and management of implantable cardiac electronic devices. Anaesthetists should be encouraged to play a proactive role in pre‐operative risk stratification and make timely multidisciplinary referrals if necessary. A personalised approach to pre‐operative cardiac optimisation enables a safer peri‐operative journey for at‐risk patients undergoing major surgery. | - |
dc.language | eng | - |
dc.publisher | Wiley-Blackwell Publishing Ltd. The Journal's web site is located at http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2044 | - |
dc.relation.ispartof | Anaesthesia | - |
dc.rights | This is the peer reviewed version of the following article: [FULL CITE], which has been published in final form at [Link to final article using the DOI]. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions. | - |
dc.subject | cardiac morbidity: pre‐operative factors | - |
dc.subject | heart failure | - |
dc.subject | hypertension | - |
dc.subject | valvular disease | - |
dc.title | Pre-operative cardiac optimization: a directed review | - |
dc.type | Article | - |
dc.identifier.email | Ip, LKK: ipky@hku.hk | - |
dc.identifier.email | Tsai, PNW: nwtsai@hku.hk | - |
dc.identifier.email | Irwin, MG: mgirwin@hku.hk | - |
dc.identifier.authority | Irwin, MG=rp00390 | - |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1111/anae.14511 | - |
dc.identifier.pmid | 30604417 | - |
dc.identifier.scopus | eid_2-s2.0-85059456089 | - |
dc.identifier.hkuros | 299999 | - |
dc.identifier.volume | 74 | - |
dc.identifier.issue | S1 | - |
dc.identifier.spage | 67 | - |
dc.identifier.epage | 69 | - |
dc.identifier.isi | WOS:000454713100010 | - |
dc.publisher.place | United Kingdom | - |
dc.identifier.issnl | 0003-2409 | - |